Remote Patient Monitoring Market by Product ([Blood Glucose, Respiratory, Blood Pressure, Fetal, Weight Monitoring] [Wearable, Portable, Benchtop]) Application (Diabetes, Oncology, Cardiovascular, Neurological Disorders) End User - Global Forecast to 2031

Remote Patient Monitoring Market by Product ([Blood Glucose, Respiratory, Blood Pressure, Fetal, Weight Monitoring] [Wearable, Portable, Benchtop]) Application (Diabetes, Oncology, Cardiovascular, Neurological Disorders) End User - Global Forecast to 2031

Remote Patient Monitoring Market by Product ([Blood Glucose, Respiratory, Blood Pressure, Fetal, Weight Monitoring] [Wearable, Portable, Benchtop]), Application (Diabetes, Oncology, Cardiovascular, Neurological Disorders), End User—Global Forecast to 2031

The global remote patient monitoring market is projected to reach $116.84 billion by 2031, at a CAGR of 13.7% from 2024 to 2031.

Following a comprehensive primary and secondary study and an in-depth analysis of the market scenario, this report provides the key drivers, restraints, challenges, and opportunities of the industry. This market is driven by the increasing geriatric population, rising prevalence of chronic diseases, shortage of healthcare professionals, growing awareness regarding the benefits of RPM, such as convenience and improved patient outcomes, rising need to reduce healthcare costs, and favorable government initiatives promoting remote patient monitoring.

Furthermore, technological advancements in telehealth & remote patient monitoring, emerging economies with growing patient populations, increasing adoption of wearable devices, advancements in sensor technologies, and integration of artificial intelligence with RPM provide a significant growth opportunity for this market. However, data accuracy & reliability concerns, barriers limiting the use of remote patient monitoring technologies such as limited access, and low technology literacy among patients restrain the growth of the market. Additionally, data security & privacy concerns and increased overhead expenses due to the need for additional staff to manage the RPM system are challenging factors in the market.

Among products, in 2024, the monitoring devices segment is expected to account for the largest share of the remote patient monitoring market. The large share of this segment is attributed to factors such as the increasing prevalence of various chronic diseases, the rising elderly population, favorable regulatory scenarios, technological advancements in sensor technology, the rising demand for personalized healthcare, and the integration of artificial intelligence and machine learning in monitoring devices.

Among applications, in 2024, the diabetes segment is expected to account for the largest share of the remote patient monitoring market. Diabetes was traditionally viewed as a predominantly inherited disease but is increasingly recognized as a lifestyle-related condition due to its rapid prevalence. The large share of the segment is due to factors such as the utilization of telehealth during diabetes management, the increasing prevalence of diabetes, and the increased need to monitor diabetic patients.

Among end users, in 2024, the home-care settings segment is expected to account for the largest share of the remote patient monitoring market. This segment's large market share is attributed to the growing shift towards home-care settings, the rise in chronic diseases among the elderly, the shortage of healthcare professionals, and increasing consumer awareness regarding the monitoring of chronic conditions through RPM tools.

An in-depth analysis of the geographical scenario of the global remote patient monitoring market provides detailed qualitative and quantitative insights for the five major geographies: North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Latin America, and the Middle East & Africa. In 2024, North America is expected to account for the largest share of the global remote patient monitoring market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Asia-Pacific is expected to be the fastest-growing region of the global remote patient monitoring market. This growth is primarily driven by the increasing healthcare expenditure, rising geriatric population, rising prevalence of chronic diseases, growing consumer awareness, increasing personal disposable incomes, and a large target population, thereby supporting the market growth.

The key players operating in the global remote patient monitoring market are Medtronic plc (Ireland), Koninklijke Philips N.V. (Netherlands), OMRON Corporation (Japan), Boston Scientific Corporation (U.S.), Abbott Laboratories (U.S.), Siemens Healthineers AG (Germany), GE HealthCare Technologies, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), Baxter International, Inc. (U.S.), Oracle Corporation (U.S.), DexCom, Inc. (U.S.), and VitalConnect, Inc. (U.S.).

Scope of the Report:

Remote Patient Monitoring Market Assessment–by Product

Monitoring Devices
Monitoring Devices, by Functionality
Blood Glucose Monitoring Devices
Cardiac Monitoring Devices
Neurological Monitoring Devices
Respiratory Monitoring Devices
Multiparameter Monitoring Devices
Blood Pressure Monitoring Devices
Fetal and Neonatal Monitoring Devices
Weight Monitoring Devices
Other Monitoring Devices

Note: Other monitoring devices include temperature monitors, brain monitoring (EEG), and prothrombin monitors.

Monitoring Devices, by Type
Wearable Monitoring Devices
Portable Monitoring Devices
Bench-top Monitoring Devices
Software
Services

Remote Patient Monitoring Market Assessment–by Application

Diabetes
Cardiovascular Diseases
Neurological Diseases
Respiratory Diseases
Oncology
Other Applications

Note: Other applications include maternity care, post-surgery monitoring, elderly care, medical adherence, and sleep monitoring.

Remote Patient Monitoring Market Assessment–by End User

Home-care Settings
Hospitals
Long-term Care Facilities
Other End Users

Note: Other end users include ambulatory care, healthcare payers, and clinical research organizations

Remote Patient Monitoring Market Assessment–by Geography

North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe (RoE)
Asia-Pacific (APAC)
China
Japan
India
Rest of APAC (RoAPAC)
Latin America
Middle East & Africa

Remote Patient Monitoring Market - Report Summary

Report Metrics	Details
Years Considered	2022 - 2031
Base Year	2023
Forecast Period	2024-2031
Page Count	247
Units Referenced	Value (USD Million)
Segments/Key Topics	Market by Product, Application, End User, and Geography
Regions Covered	North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa
Key Companies Mentioned	Medtronic plc (Ireland), Koninklijke Philips N.V. (Netherlands), OMRON Corporation (Japan), Boston Scientific Corporation (U.S.), Abbott Laboratories (U.S.), Siemens Healthineers AG (Germany), GE HealthCare Technologies, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), Baxter International, Inc. (U.S.), Oracle Corporation (U.S.), DexCom, Inc. (U.S.), and VitalConnect, Inc. (U.S.)

FAQs About the Report

What is the scope of the remote patient monitoring market study?

This market study covers the market sizes & forecasts of the remote patient monitoring market based on product, application, end user, and geography. It also provides the value analysis of various segments and subsegments of the remote patient monitoring market at the regional and country levels.

What revenue is generated from the sale of remote patient monitoring products worldwide? At what rate is their demand expected to grow for the next 5–7 years?

The remote patient monitoring market is projected to reach $116.84 billion by 2031, at a CAGR of 13.7% during the forecast period of 2024–2031.

What are the various products of remote patient monitoring, and which product segment holds the major share market?

Based on product, the remote patient monitoring market is segmented into monitoring devices, software, and services. In 2024, the monitoring devices segment is expected to account for the largest share of the remote patient monitoring market due to the increasing prevalence of chronic diseases, increasing awareness and utilization of telehealth and RPM technologies, increasing consumer awareness regarding the monitoring of chronic diseases, the rising demand for personalized healthcare, and the integration of artificial intelligence (AI) and machine learning (ML) in monitoring devices.

What are the various applications involved in remote patient monitoring, and which application segment holds the major share of the market?

Based on application, the remote patient monitoring market is segmented into diabetes, cardiovascular diseases, neurological disorders, respiratory diseases, oncology, and other applications. In 2024, the diabetes segment is expected to account for the largest share of the remote patient monitoring market due to the surge in the utilization of telehealth, the increased need to monitor diabetes patients, and the increasing prevalence of chronic diseases.

What are the various end users in the remote patient monitoring market, and which end user segment holds the major share of the market?

Based on end user, the remote patient monitoring market is segmented into home-care settings, hospitals, long-term care facilities, and other end users. In 2024, the home-care settings segment is expected to account for the largest share of the remote patient monitoring market due to the growing shift towards home-care settings, rise in chronic diseases among the elderly population, shortage of healthcare professionals, and increasing consumer awareness regarding the monitoring of chronic conditions through RPM tools.

What are the key factors supporting the growth of this market? What are the major opportunities for the market players in the remote patient monitoring market?

The growth of this market is driven by the increasing geriatric population, rising prevalence of chronic diseases, the global shortage of healthcare professionals, growing awareness regarding the benefits of RPM, such as convenience and improved patient outcomes, the rising need to reduce healthcare costs, and favorable government initiatives promoting remote patient monitoring.

Furthermore, technological advancements in telehealth & remote patient monitoring, emerging economies with growing patient populations, increasing adoption of wearable devices, advancements in sensor technologies, and integration of artificial intelligence (AI) with RPM are expected to provide significant growth opportunities for the players operating in this market.

What are the factors hindering the growth of the remote patient monitoring market?

Data accuracy & reliability concerns, barriers limiting the use of remote patient monitoring technologies such as limited access, and low technology literacy among patients restrain the market’s growth. Additionally, data security & privacy concerns and increased overhead expenses due to the need for additional staff to manage RPM systems are challenging factors in the market.

Who are the major players operating in the remote patient monitoring market?

The key players operating in the remote patient monitoring market are Medtronic plc (Ireland), Koninklijke Philips N.V. (Netherlands), OMRON Corporation (Japan), Boston Scientific Corporation (U.S.), Abbott Laboratories (U.S.), Siemens Healthineers AG (Germany), GE HealthCare Technologies, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), Baxter International, Inc. (U.S.), Oracle Corporation (U.S.), DexCom, Inc. (U.S.), and VitalConnect, Inc. (U.S.).

Which regions/countries are expected to offer significant growth opportunities for the vendors operating in the remote patient monitoring market?

The Asia-Pacific region is slated to witness the fastest growth rate during the forecast period and subsequently offer significant growth opportunities for the players operating in this market. The high market growth in Asia-Pacific is driven by increasing healthcare expenditures, growing consumer awareness, increasing personal disposable incomes, a large target population, and the increasing prevalence of chronic and infectious diseases.